A Long-Term Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)
This is an observational study designed to follow patients with RA who have had an
inadequate response to one or more anti-TNF therapies and who will receive Rituxan.
Approximately 1000 patients in the United States with RA who have had an inadequate response
to anti-TNF therapies and who will receive Rituxan therapy will be recruited. There is no
protocol mandated treatment assignment in this study. Patients will be evaluated and
treated according to their physician`s standard practice and discretion.
Study Status: Active, not recruiting
Information provided by:
Study Type: Interventional
Study Design: Observational Model: Cohort, Time Perspective: Prospective
The Cleveland Clinic Foundation
Cleveland, Ohio 44195
Swati Tole, M.D., M.S.., Study Director